Skip to content

← All news

Markets

Jazz Pharmaceuticals stock rises after FDA approves Ziihera

2 sources ·2 articles ·Aug 26, 01:39 UTC Jazz Pharmaceuticals

2 outlets - including Seekingalpha and Investing - are covering this story.

Covered by 2 outlets

Seekingalpha 1 Investing 1

All coverage · 2 articles

Seeking Alpha ·Aug 26, 01:39 UTC

Jazz Pharmaceuticals plc (JAZZ) Discusses FDA Approval and Commercial Launch of ZIIHERA for First-Line HER2-Positive GEA Transcript

Investing.com Canada ·Aug 25, 19:20 UTC

Jazz Pharmaceuticals stock rises after FDA approves Ziihera